Wednesday, March 11, 2015

Market Roundup | 10 March 2015


FBMKLCI   1789.73  -2.01pts (-0.11%)      Volume 2.538b   Value RM2.319b

 

1)The KLCI was trading firmer before selective blues were hit down during auction led by SIME-2%, IOI-2%, and GENT-1%. Bourses were mostly lower as led by HSI -0.94% after China's inflation grew more than expected, SHCOMP fell 0.49% while the NIKKEI fell 0.67% despite the yen reaching an 8 year low against the USD. TECHNOLOGY +0.78% outperformed boosted by INARI +1.54%, GHLSYS +5.02%, UNISEM +0.94%, JCY +0.69%; while the PLANTATION index -0.79% lost the most grounds weighed by IOICORP -1.94%, SOP -1.07%, THPLANT -1.25% after exports to China fell and inventory decreased less than expected. Market breadth was positive with gainers edging losers by 457 : 350. Futures closed at 1781 (8pts discount).

 

2) Heavyweights : DIGI -2.52% RM6.18, SIME -1.82% RM9.17, IOICORP -1.94% RM4.55, AXIATA -0.69% RM7.11, GENTING -1.07% RM8.30, PCHEM -1.15% RM5.15, CIMB +2.58% RM5.95, SKPETRO +3.89% RM2.40.

 

3) DBT: SUMATEC 46mil @ RM0.2057 (1.32% PUC), KANGER 43.3mil @ RM0.38 (8.39% PUC), MEXTER 1.6mil @ RM0.05.

 

4) Situational:-

BRAHIMS +11.6% RM0.96 - Stock resumed trading today after it announced proposal to acquire The Chicken Rice Shop that is still under 'negotiation'. Brahim's said its board of directors always strove to create and increase the shareholders' value. However, at this juncture, the terms and conditions of the proposed acquisition have yet to be agreed upon.

 

PUNCAK -6.29% RM2.53 / KPS -4.73% RM1.41 - The water deal between the Federal and Selangor governments has lapsed on 9 Mar and will not be extended, said Selangor Menteri Besar Mohamed Azmin Ali. Azmin said the Federal Government had breached the terms of the agreement and the state government would not grant a third extension.

 

5) Pharma

Pharmaniaga entered into a Supply Agreement for PLSB to undertake the services of purchasing, storing, supplying and delivering to UKM of pharmaceutical products approved by UKM as therein specified.

 

The value of the Approved Products to be supplied to UKM is not stipulated in the Supply Agreement. Hence, the total value of the Supply Agreement will depend on the actual volume, the agreed unit price of the Approved Products and scope of services rendered from time-to-time during the Contract Period stipulated in the Supply Agreement.

The duration of Supply Agreement, subject to the terms and conditions thereto, shall commence from 10 March 2015, being the date of the Supply Agreement and ends on 30 November 2019.

 

+Ve as the MOF remains its largest customer with higher allocations in pharmaceutical and medical supplies under the last Budget. Fairly valued at 15x current PE with a decent yield of 4.5%. Hold.

 

6) Market – Current view maintain as market continues to drift lower as foreign funds exit with the RM/USD continuing to achieve new 6yr lows.